Speaking on 'Novel technology for the rapid discovery of cell lines producing high titer therapeutic proteins' at 19th meeting of the Japanese Association for Animal Cell Technology (JAACT)
Chris Mann, chief scientist at Genetix, has been invited to speak on 'Novel technology for the rapid discovery of cell lines producing high titer therapeutic proteins' at the 19th Annual and International Meeting of the Japanese Association for Animal Cell Technology (JAACT).
Kyoto - one of the oldest cities in Japan and once the country's capital - plays host to the conference from 26-28 September, 2006.
Dr Mann's presentation will form part of Session 3 - 'Production of Biologicals' - held during the afternoon of Thursday 28 September.
With greater market acceptance of therapeutic proteins and an increasing number of companies competing in the sector, competitive advantage now derives from efficient and rapid screening of protein producing cell lines.
Genetix technology offers a powerful alternative to current procedures.
Mann will present details of how, using this new technology, thousands of cell clones can be screened in a single step, with only the best secretors collected.
Importantly, timescales can be reduced from around 60 days to less than 14 days, and productivity increases of between five and ten-fold achieved.
